(introduction...)
The ideal intervention for the reduction of mother-to-child
transmission would be one that is widely applicable in resource poor
settings252. Vaginal disinfection and vitamin A administration would
not require identification of HIV positive women, but would be applicable to all
pregnant women. The minimum requirements for the implementation of other
interventions in health services include253:
· access to and use
of appropriate antenatal, intrapartum and postpartum care with adequately
trained health workers
· adequate pre and post test
counselling services
· ability to afford the cost of
reliable HIV testing
· appropriate laboratory
facilities to monitor blood parameters during long regimen
· delivery units with access to
disinfectants, gloves and clean needles
· acceptance and uptake of the
intervention by HIV-infected women
· a regimen that is logistically
possible to implement in terms of dosing times and routes, drug storage and
distribution
· a regimen which is affordable
for the health service.
The widespread implementation of strategies to prevent
mother-to-child transmission of HIV presents a number of challenges to the
existing antenatal and obstetric services. The need for such strategies is
greatest in the most resource constrained settings. The provision of
interventions to prevent mother-to-child transmission of HIV should not further
overburden existing services. In many areas, antenatal care services are not
sufficiently available, accessible or utilized and they may not be of adequate
quality to take on these interventions. These services will need to be
strengthened in the years ahead in order to deliver mother-to-child transmission
prevention strategies effectively.
In addition if interventions are introduced into clinical
practice to decrease the risk of mother-to-child transmission their
effectiveness outside of the context of a randomized controlled trial should be
monitored. Careful follow-up of the mothers and infants of such programmes will
be essential to determine the generalisability of clinical trial results to the
practical setting.
The management of HIV infection and AIDS is changing rapidly.
New drugs become available and are rapidly adopted into clinical practice with
little rigorous evaluation of their effectiveness. In pregnancy the situation is
little different. Within one month in 1999, four substantial randomized trials
of interventions aimed at decreasing the risk of mother-to-child transmission of
HIV infection were published. Many more trials are on-going and can be expected
to report in the next two years. The following section, therefore, represents
the evidence that was available at the end of May 1999. As new randomized trials
are published they will be incorporated into an ongoing systematic review and
meta-analysis of interventions aimed at decreasing the risk of mother-to-child
transmission of HIV infection published in the Cochrane
Library254.